B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis

Journal of Autoimmunity

Volumn 81, Issue , 2017, Pages 34-43

  Amara, Khaled ^a   Clay, Elizabeth ^b   Yeo, Lorraine ^b   Ramsköld, Daniel ^a   Spengler, Julia ^b   Sippl, Natalie ^a   Cameron, James A ^b   Israelsson, Lena ^a   Titcombe, Philip J ^a   Grönwall, Caroline ^a   Sahbudin, Ilfita ^b   Filer, Andrew ^b   Raza, Karim ^b,c   Malmström, Vivianne ^a   Scheel Toellner, Dagmar ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Antibodies; Autoimmunity; B cells; FcRL4; IRTA1; Rheumatoid arthritis

Indexed keywords

AUTOANTIGEN; B LYMPHOCYTE RECEPTOR; CD19 ANTIGEN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN RECEPTOR; IMMUNOGLOBULIN RECEPTOR FCRL4; MONOCLONAL ANTIBODY; RECOMBINANT ANTIBODY; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; FC RECEPTOR; FCRL4 PROTEIN, HUMAN; IMMUNOGLOBULIN; TRANSCRIPTOME;

ADULT; AGED; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SECRETING CELL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE SUBPOPULATION; CELL ISOLATION; CELL SURFACE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; DAS28; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOREACTIVITY; LYMPHOCYTE DIFFERENTIATION; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; MOLECULAR CLONING; MOLECULAR PATHOLOGY; MUTATIONAL ANALYSIS; PLASMA CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; RNA SEQUENCE; SOMATIC MUTATION; SYNOVIAL FLUID; SYNOVIUM; T LYMPHOCYTE; TRANSIENT TRANSFECTION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; MUTATION;

AGED; ARTHRITIS, RHEUMATOID; AUTOANTIGENS; AUTOIMMUNITY; B-LYMPHOCYTES; BIOMARKERS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN ISOTYPES; IMMUNOGLOBULINS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MUTATION; RECEPTORS, FC; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; TRANSCRIPTOME;

EID: 85017118390     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2017.03.004     Document Type: Article

References (56)

1. Edwards, J.C., Cambridge, G., Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatol. Oxf. Engl. 40 (2001), 205–211.
2. Klareskog, L., Amara, K., Malmstrom, V., Adaptive immunity in rheumatoid arthritis: anticitrulline and other antibodies in the pathogenesis of rheumatoid arthritis. Curr. Opin. Rheumatol. 26 (2014), 72–79.
3. Snir, O., Widhe, M., von Spee, C., Lindberg, J., Padyukov, L., Lundberg, K., et al. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Ann. Rheum. Dis. 68 (2009), 736–743.
4. Amara, K., Steen, J., Murray, F., Morbach, H., Fernandez-Rodriguez, B.M., Joshua, V., et al. Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. J. Exp. Med. 210 (2013), 445–455.
5. Kleyer, A., Finzel, S., Rech, J., Manger, B., Krieter, M., Faustini, F., et al. Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies. Ann. Rheum. Dis. 73 (2014), 854–860.
6. Harre, U., Georgess, D., Bang, H., Bozec, A., Axmann, R., Ossipova, E., et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J. Clin. Investig. 122 (2012), 1791–1802.
7. Kuhn, K.A., Kulik, L., Tomooka, B., Braschler, K.J., Arend, W.P., Robinson, W.H., et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J. Clin. Investig. 116 (2006), 961–973.
8. Trouw, L.A., Haisma, E.M., Levarht, E.W., van der Woude, D., Ioan-Facsinay, A., Daha, M.R., et al. Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum. 60 (2009), 1923–1931.
9. Keystone, E., Emery, P., Peterfy, C.G., Tak, P.P., Cohen, S., Genovese, M.C., et al. Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies. Ann. Rheum. Dis. 68 (2009), 216–221.
10. Cambridge, G., Perry, H.C., Nogueira, L., Serre, G., Parsons, H.M., De La Torre, I., et al. The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment. J. Autoimmun. 50 (2014 May), 67–76, 10.1016/j.jaut.2013.12.002 Epub 2013 Dec 22.
11. Martin, F., Chan, A.C., B cell immunobiology in disease: evolving concepts from the clinic. Annu. Rev. Immunol. 24 (2006), 467–496.
12. Anolik, J.H., Looney, R.J., Lund, F.E., Randall, T.D., Sanz, I., Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets. Immunol. Res. 45 (2009), 144–158.
13. Yeo, L., Toellner, K.M., Salmon, M., Filer, A., Buckley, C.D., Raza, K., et al. Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis. Ann. Rheum. Dis. 70 (2011), 2022–2028.
14. Yeo, L., Lom, H., Juarez, M., Snow, M., Buckley, C.D., Filer, A., et al. Expression of FcRL4 defines a pro-inflammatory, RANKL-producing B cell subset in rheumatoid arthritis. Ann. Rheum. Dis. 74 (2015), 928–935.
15. Kong, Y.Y., Yoshida, H., Sarosi, I., Tan, H.L., Timms, E., Capparelli, C., et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397 (1999), 315–323.
16. Boumans, M.J., Thurlings, R.M., Yeo, L., Scheel-Toellner, D., Vos, K., Gerlag, D.M., et al. Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis. Ann. Rheum. Dis. 71 (2012), 108–113.
17. Davis, R.S., Wang, Y.H., Kubagawa, H., Cooper, M.D., Identification of a family of Fc receptor homologs with preferential B cell expression. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 9772–9777.
18. Hatzivassiliou, G., Miller, I., Takizawa, J., Palanisamy, N., Rao, P.H., Iida, S., et al. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity 14 (2001), 277–289.
19. Sohn, H.W., Krueger, P.D., Davis, R.S., Pierce, S.K., FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling. Blood 118 (2011), 6332–6341.
20. Liu, Y., Bezverbnaya, K., Zhao, T., Parsons, M.J., Shi, M., Treanor, B., et al. Involvement of the HCK and FGR src-family kinases in FCRL4-mediated immune regulation. J. Immunol. 194 (2015), 5851–5860.
21. Ehrhardt, G.R., Davis, R.S., Hsu, J.T., Leu, C.M., Ehrhardt, A., Cooper, M.D., The inhibitory potential of Fc receptor homolog 4 on memory B cells. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 13489–13494.
22. Falini, B., Tiacci, E., Pucciarini, A., Bigerna, B., Kurth, J., Hatzivassiliou, G., et al. Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). Blood 102 (2003), 3684–3692.
23. Ehrhardt, G.R., Hijikata, A., Kitamura, H., Ohara, O., Wang, J.Y., Cooper, M.D., Discriminating gene expression profiles of memory B cell subpopulations. J. Exp. Med. 205 (2008), 1807–1817.
24. Bob, R., Falini, B., Marafioti, T., Paterson, J.C., Pileri, S., Stein, H., Nodal reactive and neoplastic proliferation of monocytoid and marginal zone B cells: an immunoarchitectural and molecular study highlighting the relevance of IRTA1 and T-bet as positive markers. Histopathology 63 (2013), 482–498.
25. Wilson, T.J., Fuchs, A., Colonna, M., Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG. J. Immunol. 188 (2012), 4741–4745.
26. Arnett, F.C., Edworthy, S.M., Bloch, D.A., McShane, D.J., Fries, J.F., Cooper, N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31 (1988), 315–324.
27. Amara K. CE, Yeo L., Ramsköld D, Spengler J., Sippl N., Cameron J.A., Israelsson L., Titcombe P.J., Grönwall C., Sahbudin I., Filer A., Raza K., Malmström, V., Scheel-Toellner, D. Companion paper to: Amara, K. et al Journal of Autoimmunity, 2017, in press, including detailed clinical characteristics and URL link to GEO dataset. Data in Brief, 2017, DIB-D-17–00232.
28. Hidalgo, E., Essex, S.J., Yeo, L., Curnow, S.J., Filer, A., Cooper, M.S., et al. The response of T cells to interleukin-6 is differentially regulated by the microenvironment of the rheumatoid synovial fluid and tissue. Arthritis Rheum. 63 (2011), 3284–3293.
29. Tiller, T., Meffre, E., Yurasov, S., Tsuiji, M., Nussenzweig, M.C., Wardemann, H., Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J. Immunol. Methods 329 (2008), 112–124.
30. Wardemann, H., Yurasov, S., Schaefer, A., Young, J.W., Meffre, E., Nussenzweig, M.C., Predominant autoantibody production by early human B cell precursors. Science 301 (2003), 1374–1377.
31. Kabat, E.A., Wu, T.T., Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites. J. Immunol. 147 (1991), 1709–1719.
32. Rogosch, T., Kerzel, S., Hoi, K.H., Zhang, Z., Maier, R.F., Ippolito, G.C., et al. Immunoglobulin analysis tool: a novel tool for the analysis of human and mouse heavy and light chain transcripts. Front. Immunol., 3, 2012, 176.
33. Lundberg, K., Kinloch, A., Fisher, B.A., Wegner, N., Wait, R., Charles, P., et al. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum. 58 (2008), 3009–3019.
34. Snir, O., Widhe, M., Hermansson, M., von Spee, C., Lindberg, J., Hensen, S., et al. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients. Arthritis Rheum. 62 (2010), 44–52.
35. Verpoort, K.N., Cheung, K., Ioan-Facsinay, A., van der Helm-van Mil, A.H., de Vries-Bouwstra, J.K., Allaart, C.F., et al. Fine specificity of the anti-citrullinated protein antibody response is influenced by the shared epitope alleles. Arthritis Rheum. 56 (2007), 3949–3952.
36. Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D.R., et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7 (2012), 562–578.
37. Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29 (2013), 15–21.
38. Ramskold, D., Wang, E.T., Burge, C.B., Sandberg, R., An abundance of ubiquitously expressed genes revealed by tissue transcriptome sequence data. PLoS Comput. Biol., 5, 2009, e1000598.
39. Love, M.I., Huber, W., Anders, S., Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol., 15, 2014, 550.
40. Kim, S., Davis, M., Sinn, E., Patten, P., Hood, L., Antibody diversity: somatic hypermutation of rearranged VH genes. Cell 27 (1981), 573–581.
41. Ehrhardt, G.R., Hsu, J.T., Gartland, L., Leu, C.M., Zhang, S., Davis, R.S., et al. Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J. Exp. Med. 202 (2005), 783–791.
42. Isnardi, I., Ng, Y.S., Menard, L., Meyers, G., Saadoun, D., Srdanovic, I., et al. Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood 115 (2010), 5026–5036.
43. Thorarinsdottir, K., Camponeschi, A., Gjertsson, I., Martensson, I.L., CD21 -/low B cells: a snapshot of a unique B cell subset in Health and disease. Scand. J. Immunol. 82 (2015), 254–261.
44. Silverman, G.J., Goldfien, R.D., Chen, P., Mageed, R.A., Jefferis, R., Goni, F., et al. Idiotypic and subgroup analysis of human monoclonal rheumatoid factors. Implications for structural and genetic basis of autoantibodies in humans. J. Clin. Investig. 82 (1988), 469–475.
45. Charles, E.D., Brunetti, C., Marukian, S., Ritola, K.D., Talal, A.H., Marks, K., et al. Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset. Blood 117 (2011), 5425–5437.
46. Kim, H.J., Berek, C., B cells in rheumatoid arthritis. Arthritis Res. 2 (2000), 126–131.
47. Glanville, J., Zhai, W., Berka, J., Telman, D., Huerta, G., Mehta, G.R., et al. Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 20216–20221.
48. Mahmoudi, M., Edwards, J.Y., Bell, D.A., Cairns, E., V region gene analysis of human IgM hybridoma monoclonal anti-Sm antibodies. Lupus 6 (1997), 578–589.
49. Lecerf, J.M., Chen, Y., Richalet-Secordel, P., Wang, X., Stollar, B.D., Autoreactivity of human VH domains from cDNA libraries: analysis with a bacterial expression system. J. Immunol. 161 (1998), 1274–1283.
50. Catrina, A.I., Ytterberg, A.J., Reynisdottir, G., Malmstrom, V., Klareskog, L., Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis. Nat. Rev. Rheumatol. 10 (2014), 645–653.
51. Rosenstein, E.D., Greenwald, R.A., Kushner, L.J., Weissmann, G., Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis. Inflammation 28 (2004), 311–318.
52. Chervonsky, A.V., Microbiota and autoimmunity. Cold Spring Harb. Perspect. Biol., 5, 2013, a007294.
53. Lindqvist, E., Eberhardt, K., Bendtzen, K., Heinegard, D., Saxne, T., Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann. Rheum. Dis. 64 (2005), 196–201.
54. Svard, A., Kastbom, A., Reckner-Olsson, A., Skogh, T., Presence and utility of IgA-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis: the Swedish TIRA project. Arthritis Res. Ther., 10, 2008, R75.
55. Corsiero, E., Bombardieri, M., Carlotti, E., Pratesi, F., Robinson, W., Migliorini, P., et al. Single cell cloning and recombinant monoclonal antibodies generation from RA synovial B cells reveal frequent targeting of citrullinated histones of NETs. Ann. Rheum. Dis. 75 (2016), 1866–1875.
56. Li, S., Yu, Y., Yue, Y., Liao, H., Xie, W., Thai, J., et al. Autoantibodies from single circulating plasmablasts react with citrullinated antigens and porphyromonas gingivalis in rheumatoid arthritis. Arthritis Rheumatol. 68 (2016), 614–626.